nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Assessing the strength of evidence for a causal effect of respiratory syncytial virus lower respiratory tract infections on subsequent wheezing illness: a systematic review and meta-analysis
|
Brunwasser, Steven M |
|
|
8 |
8 |
p. 795-806 |
artikel |
2 |
Child poverty, food insecurity, and respiratory health during the COVID-19 pandemic
|
Sinha, Ian P |
|
|
8 |
8 |
p. 762-763 |
artikel |
3 |
Correction to Lancet Respir Med 2020; 8: 758–60
|
|
|
|
8 |
8 |
p. e69 |
artikel |
4 |
COVID-19-associated acute respiratory distress syndrome: is a different approach to management warranted?
|
Fan, Eddy |
|
|
8 |
8 |
p. 816-821 |
artikel |
5 |
COVID-19 casts light on respiratory health inequalities
|
The Lancet Respiratory Medicine, |
|
|
8 |
8 |
p. 743 |
artikel |
6 |
Dance group enriches lives of people living with breathlessness
|
Williams, Siân |
|
|
8 |
8 |
p. 763-764 |
artikel |
7 |
Delivering evidence-based critical care for mechanically ventilated patients with COVID-19
|
Salluh, Jorge I F |
|
|
8 |
8 |
p. 756-758 |
artikel |
8 |
Diagnostic value of TBLC in idiopathic pulmonary fibrosis
|
Moua, Teng |
|
|
8 |
8 |
p. 747-748 |
artikel |
9 |
Feasibility and physiological effects of prone positioning in non-intubated patients with acute respiratory failure due to COVID-19 (PRON-COVID): a prospective cohort study
|
Coppo, Anna |
|
|
8 |
8 |
p. 765-774 |
artikel |
10 |
Gefapixant, a P2X3 receptor antagonist, for the treatment of refractory or unexplained chronic cough: a randomised, double-blind, controlled, parallel-group, phase 2b trial
|
Smith, Jaclyn A |
|
|
8 |
8 |
p. 775-785 |
artikel |
11 |
Health equity and distributive justice considerations in critical care resource allocation
|
Galiatsatos, Panagis |
|
|
8 |
8 |
p. 758-760 |
artikel |
12 |
Identification of pathophysiological patterns for triage and respiratory support in COVID-19
|
Camporota, Luigi |
|
|
8 |
8 |
p. 752-754 |
artikel |
13 |
Is there a causal relationship between respiratory syncytial virus lower respiratory tract infection and chronic wheezing?
|
Bem, Reinout A |
|
|
8 |
8 |
p. 749-750 |
artikel |
14 |
Managing unexplained chronic cough in adults: what are the unmet needs?
|
Irwin, Richard S |
|
|
8 |
8 |
p. 745-747 |
artikel |
15 |
Prognostic value of transbronchial lung cryobiopsy for the multidisciplinary diagnosis of idiopathic pulmonary fibrosis: a retrospective validation study
|
Tomassetti, Sara |
|
|
8 |
8 |
p. 786-794 |
artikel |
16 |
Prone positioning in non-intubated patients with COVID-19: raising the bar
|
Munshi, Laveena |
|
|
8 |
8 |
p. 744-745 |
artikel |
17 |
Pulmonary fibrosis and COVID-19: the potential role for antifibrotic therapy
|
George, Peter M |
|
|
8 |
8 |
p. 807-815 |
artikel |
18 |
Pulmonary fibrosis secondary to COVID-19: a call to arms?
|
Spagnolo, Paolo |
|
|
8 |
8 |
p. 750-752 |
artikel |
19 |
Respiratory research funding is inadequate, inequitable, and a missed opportunity
|
Williams, Siân |
|
|
8 |
8 |
p. e67-e68 |
artikel |
20 |
The girl with the swampy lungs
|
Thorley, Jennifer |
|
|
8 |
8 |
p. 761 |
artikel |
21 |
Therapeutic blockade of granulocyte macrophage colony-stimulating factor in COVID-19-associated hyperinflammation: challenges and opportunities
|
Mehta, Puja |
|
|
8 |
8 |
p. 822-830 |
artikel |
22 |
Use of aerosolised medications at home for COVID-19
|
Ari, Arzu |
|
|
8 |
8 |
p. 754-756 |
artikel |